Paul Hays has devoted his entire career to animal health. Prior to joining Virbac in 2013, he served as Vice President Global Diagnostics at Pfizer Animal Health and led the Synbiotics Corporation integration into Pfizer’s businesses around the world. Before that, Mr. Hays held senior management roles at Boehringer Ingelheim, as well as the Executive Vice President, U.S. Business Operations role. Earlier still, he was instrumental in the U.S. start-up team for CIBA Animal Health, which later became Novartis, and began his career with Coopers Animal Health as a sales representative. Mr. Hays holds a bachelor’s degree in animal science from the University of Missouri. At Virbac, he oversees all corporate functions for Virbac North America and is responsible for the growth and profitability of both the U.S. and Canadian operations.